|
|
|
Eli Lilly |
|
|
Eli Lilly was founded by pharmaceutical chemist, Eli Lilly, on 10th May 1876. Its global headquarters are at Indianapolis, Indiana (USA). In 2006 it had achieved revenues of about US$ 15.57 billion.
It has worldwide employee strength of over 41,502, of which over 8,262 are engaged in R&D activities. In 1923, Eli Lilly commercially manufactured and marketed Iletin, the first insulin product.
Eli Lilly has manufacturing facilities in over 30 countries, R&D facilities in 9 countries and conducts clinical research in more than 50 countries. Its products serve markets of about 143 countries. It spends about US$ 3129 million per year on R&D.
|
|
Eli Lily and Company (India) Pvt. Ltd. is a subsidiary of the US pharmaceutical company, Eli Lilly and Company. It was established in 1993 as Eli Lilly Ranbaxy Ltd, a 50:50 joint venture between Eli Lilly and Ranbaxy Laboratories Ltd. With the acquisition of 50% stake from Ranbaxy in 2001, Eli Lilly and Company created its Indian subsidiary as Eli Lilly and Company (India) Ltd.
In India, Eli Lilly has employee strength of about 550, which includes more than 20 clinical research professionals. Its revenues grew to Rs. 150 crore in 2003 from Rs. 8 crore in 1994. On 24th March 2007, it announced donation of US$ 50 million to fight TB infections in India. About 14 public and private organizations will join the company as international partners in this campaign.
Executive Management
Rajiv Gulati, Chairman and managing Director-Eli Lilly India Pvt. Ltd.
Sidney Taurel, Chairman and Chief Executive Officer
John Lechleiter, President and Chief Operating Officer
Scott Canute, President, Manufacturing Operations
Bryce Carmine, President, Global Brand Development Teams
Deirdre Connelly, President, Lilly USA
Newton F. Crenshaw, President and General Manager, Lilly Japan
Patrick James, President, Elanco Animal Health
Peter Johnson, Executive Director, Corporate Strategic Planning
Lorenzo Tallarigo, President, International Operations
Jacques Tapiero, President, Intercontinental Operations
Products:
Huminsulin
Xigris
Gemcite
Distaclor
ReoPro
Alimta
Contact Address:
Eli Lilly and Company (India) Pvt. Ltd.
Plot # 92, Sector 32,
Institutional Area,
Gurgaon-122001
HARYANA, INDIA
Phone : 91-124-2823000,01
Fax : 91-124-2823012, 13
Email : lillyindia@lilly.com
Website: www.lilly.com
|
|
|
|
|
|
|
|
|
| Career Institutes |
| Want to know about professional career institutes.
|
|
 |
|
|
|
|
|
|
|
|
|
|
